Matrix metalloproteinases (MMPs) are a family of zinc-dependent metalloendopeptidases that degrades extracellular matrix (ECM) components. MMPs are associated with venous wall remodelling, proliferation, migration, phenotypic and functional transformation of vascular smooth muscle cells and ECM organization under the physiological and pathophysiological conditions. We investigated possible association of genetic promoter polymorphisms of MMP2 (rs243866), MMP8 (rs11225395), MMP9 (rs3918242) and TIMP2 (rs8179090) to varicose veins development in the Slovak population. Genomic DNA from 276 Slovak individuals (138 cases, 138 controls) was genotyped for selected SNPs (rs243866, rs11225395, rs3918242 and rs8179090) using the PCR-RFLP analysis. The data were analysed by chi-squared (chi2) test, logistic regression, and Mann-Whitney test. The risk of varicose veins development was evaluated in dominant, codominant and recessive genetic models. The statistical evaluation of selected polymorphisms in patients in all three genetic models has not shown a significant risk of varicose veins development. Our study has not shown the association between selected polymorphisms and increased risk of varicose veins development in Slovak population. More evidence with broaden sample size is needed.

Department of Medical Biology Jessenius Faculty of Medicine Martin Slovakia

See more in PubMed

AMATO B, CORETTI G, COMPAGNA R, AMATO M, BUFFONE G, GIGLIOTTI D, GRANDE R, SERRA R, De FRANCISCIS S. Role of matrix metalloproteinases in non-healing venous ulcers. Int Wound J. 2015;12:641–645. doi: 10.1111/iwj.12181. PubMed DOI PMC

ARAVIND B, SAUNDERS B, NAVIN T, SANDISON A, MONACO C, PALEOLOG EM, DAVIES AH. Inhibitory effect of TIMP influences the morphology of varicose veins. Eur J Vasc Endovasc Surg. 2010;40:754–765. doi: 10.1016/j.ejvs.2010.04.028. PubMed DOI

ARECHAVALETA-VELASCO F, CUEVAS-ANTONIO R, DOMINGUEZ-LOPEZ P, ESTRADA-MOSCOSO I, IMANI-RAZAVI FS, ZEFERINO-TOQUERO M, DIAZ-CUETO L. Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer. Med Oncol. 2014;31:132. doi: 10.1007/s12032-014-0132-3. PubMed DOI

BADIER-COMMANDER C, VERBEUREN T, LEBARD C, MICHEL JB, JACOB MP. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol. 2000;192:105–112. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH670>3.0.CO;2-1. PubMed DOI

BOURBOULIA D, STETLER-STEVENSON WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20:161–168. doi: 10.1016/j.semcancer.2010.05.002. PubMed DOI PMC

CASANA R, TOLVA VS, ODERO A, JR, MALLOGGI C, PARATI G. Three-year follow-up and quality of life of endovenous radiofrequency ablation of the great saphenous vein with the ClosureFast™ procedure: Influence of BMI and CEAP class. Vascular. 2018;26:498–508. doi: 10.1177/1708538118762066. PubMed DOI

CHAMPELY S. pwr: Basic Functions for Power Analysis. R package version 1.3-0. 2020. https://CRAN.R-project.org/package=pwr .

CHEN Y, PENG W, RAFFETTO JD, KHALIL RA. Matrix metalloproteinases in remodeling of lower extremity veins and chronic venous disease. Prog Mol Biol Transl Sci. 2017;147:267–299. doi: 10.1016/bs.pmbts.2017.02.003. PubMed DOI PMC

DĘBNIAK T, JAKUBOWSKA A, SERRANO-FERNÁNDEZ P, KURZAWSKI G, CYBULSKI C, CHAUHAN SR, LAXTON RC, MALESZKA R, LUBINSKI J, YE S. Association of MMP8 gene variation with an increased risk of malignant melanoma. Melanoma Res. 2011;21:464–468. doi: 10.1097/CMR.0b013e3283485fdd. PubMed DOI

DECOCK J, LONG JR, LAXTON RC, SHU XO, HODGKINSON C, HENDRICKX W, PEARCE EG, GAO YT, PEREIRA AC, PARIDAENS R, ZHENG W, YE S. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res. 2007;67:10214–10221. doi: 10.1158/0008-5472.CAN-07-1683. PubMed DOI

DJURIĆ T, STANKOVIĆ A, KONČAR I, RADAK D, DAVIDOVIĆ L, ALAVANTIĆ D, ŽIVKOVIĆ M. Association of MMP 8 promoter gene polymorphisms with carotid atherosclerosis: preliminary study. Atherosclerosis. 2011;219:673–678. doi: 10.1016/j.atherosclerosis.2011.08.025. PubMed DOI

ELLINGHAUS E, ELLINGHAUS D, KRUSCHE P, GREINER A, SCHREIBER C, NIKOLAUS S, GIEGER C, STRAUCH K, LIEB W, ROSENSTIEL P, FRINGS N, FIEBIG A, SCHREIBER S, FRANKE A. Genome-wide association analysis for chronic venous disease identifies EFEMP1 and KCNH8 as susceptibility loci. Sci Rep. 2017;7:45652. doi: 10.1038/srep45652. PubMed DOI PMC

FENG J, CHEN Y, HUA W, SUN X, CHEN Y, LIU Y, FAN J, ZHAO Y, ZHAO L, XU X, YANG X. The MMP-8 rs11225395 promoter polymorphism increases cancer risk of non-asian populations: evidence from a meta-analysis. Biomolecules. 2019;9 doi: 10.3390/biom9100570. pii: E570. PubMed DOI PMC

FUKAYA E, FLORES AM, LINDHOLM D, GUSTAFSSON S, ZANETTI D, INGELSSON E, LEEPER NJ. Clinical and genetic determinants of varicose veins. Circulation. 2018;138:2869–2880. doi: 10.1161/CIRCULATIONAHA.118.035584. PubMed DOI PMC

GOURGOU S, DEDIEU F, SANCHO-GARNIER H. Lower limb venous insufficiency and tobacco smoking: a case control study. Am J Epidemiol. 2002;155:1007–1115. doi: 10.1093/aje/155.11.1007. PubMed DOI

GÖRMÜS U, TIMIRCI-KAHRAMAN O, ERGEN A, KUNT AT, ISBIR S, DALAN AB, ISBIR T. Expression levels of elastin and related genes in human varicose veins. Folia Biol (Praha) 2014;60:68–73. PubMed

HARENDZA S, LOVETT DH, PANZER U, LUKACS Z, KUHNL P, STAHL RAK. Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem. 2003;278:20490–20499. doi: 10.1074/jbc.M211536200. PubMed DOI

HU X, HU F, XU Y, TANG J, CHU H, ZHONG Y. Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall. Int Angiol. 2019;38:185–193. doi: 10.23736/S0392-9590.19.04144-0. PubMed DOI

HUGHES LB, BEASLEY TM, PATEL H, TIWARI HK, MORGAN SL, BAGGOTT JE, SAAG KG, McNICHOLL J, MORELAND LW, ALARCÓN GS, BRIDGES SL., JR Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis. 2006;65:1213–1218. doi: 10.1136/ard.2005.046797. PubMed DOI PMC

JOHNSON JL. Metalloproteinases in atherosclerosis. Eur J Pharmacol. 2017;816:93–106. doi: 10.1016/j.ejphar.2017.09.007. PubMed DOI

KALININ RE, SUCHKOV IA, PSHENNIKOV AS, KAMAEV AA, MZHAVANADZE ND. Concentration of matrix metalloproteinases and magnesium ions in patients with varicose veins of lower limbs (Article in Russian) Angiol Sosud Khir. 2016;22:24–28. PubMed

KUNT AT, ISBIR S, GÖRMUS U. Polymorphisms of MMP9 and TIMP2 in patients with varicose veins. In Vivo. 2015;29:461–465. PubMed

LAUHIO A, FÄRKKILÄ E, PIETILÄINEN KH, ÅSTRÖM P, WINKELMANN A, TERVAHARTIALA T, PIRILÄ E, RISSANEN A, KAPRIO J, SORSA TA, SALO T. Association of MMP-8 with obesity, smoking and insulin resistance. Eur J Clin Invest. 2016;46:757–765. doi: 10.1111/eci.12649. PubMed DOI

LAUNOIS R. Health-related quality-of-life scales specific for chronic venous disorders of the lower limbs. J Vasc Surg Venous Lymphat Disord. 2015;3:219–227. doi: 10.1016/j.jvsv.2014.08.005. PubMed DOI

MacCOLL E, KHALIL RA. Matrix metalloproteinases as regulators of vein structure and function: implications in chronic venous disease. J Pharmacol Exp Ther. 2015;355:410–428. doi: 10.1124/jpet.115.227330. PubMed DOI PMC

MATTEI J, PARNELL LD, LAI CH-Q, GARCIA-BAILO B, ADICONIS X, SHEN J, ARNETT D, DEMISSIE S, TUCKER KL, ORDOVAS JM. Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites. BMC Genet. 2009;10:45. doi: 10.1186/1471-2156-10-45. PubMed DOI PMC

MIGDALSKI Ł, KUZDAK K. The use of the VEINES-QOL/Sym questionnaire in patients operated for varicose veins. Pol Przegl Chir. 2015;87:491–498. doi: 10.1515/pjs-2015-0094. PubMed DOI

MIKOŁAJCZYK-STECYNA J, KORCZ A, GABRIEL M, PAWLACZYK L, OSZKINIS G, SŁOMSKI R. Gene polymorphism −418 G/C of tissue inhibitor of metalloproteinases 2 is associated with abdominal aortic aneurysm. J Vasc Surg. 2015;61:1114–1119. doi: 10.1016/j.jvs.2013.12.045. PubMed DOI

MOSKALENKO MI, MILANOVA SN, PONOMARENKO IV, POLONIKOV AV, CHURNOSOV MI. Study of associations of polymorphism of matrix metalloproteinases genes with the development of arterial hypertension in men. Kardiologiia. 2019;59(7S):31–39. doi: 10.18087/cardio.2598. PubMed DOI

NAGASE H, VISSE R, GILLIAN MURPHY G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562–573. doi: 10.1016/j.cardiores.2005.12.002. PubMed DOI

NEMEC P, GOLDBERGOVA M, SWOBODNIK T, POLASKOVA D, SOUCEK M, VASKU A. Polymorphism of gene promotor region for MMP-2 in rheumatoid arthritis. (Article in Czech) Vnitr Lek. 2006;52:348–354. PubMed

ONIDA S, DAVIES AH. Predicted burden of venous disease. Phlebology. 2016;31(Suppl 1):74–79. doi: 10.1177/0268355516628359. PubMed DOI

PARK KS, KIM SJ, KIM KH, KIM JC. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol. 2011;26:391–397. doi: 10.1111/j.1440-1746.2010.06504.x. PubMed DOI

PÉREZ-HERNÁNDEZ N, VARGAS-ALARCÓN G, MARTÍNEZ-RODRÍGUEZ N, MARTÍNEZ-RÍOS MA, PEÑA-DUQUE MA, PEÑA-DÍAZ ADEL, VALENTE-ACOSTA B, POSADAS-ROMERO C, MEDINA A, RODRÍGUEZ-PÉREZ JM. The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients. J Atheroscler Thromb. 2012;19:718–727. doi: 10.5551/jat.11817. PubMed DOI

PRICE SJ, GREAVES DR, WATKINS H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2001;276:7549–7558. doi: 10.1074/jbc.M010242200. PubMed DOI

RABE E, PANNIER F. Societal costs of chronic venous disease in CEAP C4, C5, C6 disease. Phlebology. 2010;25(Suppl 1):64–67. doi: 10.1258/phleb.2010.010s09. PubMed DOI

RAETZ J, WILSON M, COLLINS K. Varicose veins: Diagnosis and treatment. Am Fam Physician. 2019;99:682–688. PubMed

RAFFETTO JD, KHALIL RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008;75:346–359. doi: 10.1016/j.bcp.2007.07.004. PubMed DOI PMC

R CORE TEAM. R: A language and environment for statistical computing. R Foundation for Statistical Computing; Vienna, Austria: 2020. URL https://www.R-project.org/

SALMHOFER W. Ätiologie, nomenklatur und pathophysiologie der chronisch venösen Insuffizienz (Article in German) Wien Med Wochenschr. 2016;166:264–269. doi: 10.1007/s10354-016-0466-x. PubMed DOI

SARACINI C, BOLLI P, STICCHI E, PRATESI G, PULLI R, SOFI F, PRATESI C, GENSINI GF, ABBATE R, GIUSTI B. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm. J Vasc Surg. 2012;55:171–179. doi: 10.1016/j.jvs.2011.07.051. PubMed DOI

SEO DW, LI H, GUEDEZ L, WINGFIELD PT, DIAZ T, SALLOUM R, WEI BY, STETLER-STEVENSON WG. TIMP 2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003;114:171–180. doi: 10.1016/S0092-8674(03)00551-8. PubMed DOI

SLONKOVÁ V, SLONKOVÁ V, JR, VAŠKŮ A, VAŠKŮ V. Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2. J Eur Acad Dermatol Venereol. 2017;31:1746–1752. doi: 10.1111/jdv.14447. PubMed DOI

SERRALHEIRO P, NOVAIS A, CAIRRÃO E, MAIA C, COSTA ALMEIDA CM, VERDE I. Variability of MMP/TIMP and TGF-β1 receptors throughout the clinical progression of chronic venous disease. Int J Mol Sci. 2017;19 doi: 10.3390/ijms19010006. piiE6. PubMed DOI PMC

SHIOMI T, LEMAÎTRE V, D’ARMIENTO J, OKADA Y. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int. 2010;60:477–496. doi: 10.1111/j.1440-1827.2010.02547.x. PubMed DOI PMC

SIRIBUMRUNGWONG B, NOORIT P, WILASRUSMEE C, TEERAWATTANANON Y, THAKKINSTIAN A. Quality of life after great saphenous vein ablation in Thai patients with great saphenous vein reflux. Asian J Surg. 2017;40:295–300. doi: 10.1016/j.asjsur.2015.10.004. PubMed DOI

SUTZKO DC, OBI AT, KIMBALL AS, SMITH ME, WAKEFIELD TW, OSBORNE NH. Clinical outcomes after varicose vein procedures in octogenarians within the Vascular Quality Initiative Varicose Vein Registry. J Vasc Surg Venous Lymphat Disord. 2018;6:464–470. doi: 10.1016/j.jvsv.2018.02.008. PubMed DOI PMC

ŠTVRTINOVÁ V, ČELOVSKÁ D. Dokáže edukácia obyvateľstva znížiť výskyt kŕčových žíl a ich komplikácií na Slovensku? (Article in Slovak) Vask Med. 2017;9:18–21.

WANG XZ, DU XM, JING QM, LI XX, GU RX, WANG J, HAN YL. Impact of matrix metalloproteinase-8 gene variations on the risk of thoracic aortic dissection in a Chinese Han population. Mol Biol Rep. 2013;40:5953–5958. doi: 10.1007/s11033-013-2704-2. PubMed DOI PMC

WITTENS C, DAVIES AH, BÆKGAARD N, BROHOLM R, CAVEZZI A, CHASTANET S, De WOLF M, EGGEN C, GIANNOUKAS A, GOHEL M, KAKKOS S, LAWSON J, NOPPENEY T, ONIDA S, PITTALUGA P, THOMIS S, TOONDER I, VUYLSTEKE M, et al. ESVS GUIDELINES COMMITTEE. Editor’s choice e management of chronic venous disease: Clinical practice guidelines of the European Society for Vascular Surgery (ESVS) Eur J Vasc Endovasc Surg. 2015;49:678–737. doi: 10.1016/j.ejvs.2015.02.007. PubMed DOI

XU HM, ZHAO Y, ZHANG XM, ZHU T, FU WG. Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins. J Surg Res. 2011;168:E143–E148. doi: 10.1016/j.jss.2010.11.002. PubMed DOI

YADAV SS, MANDAL RK, SINGH MK, USMAN K, KHATTRI S. Genetic variants of matrix metalloproteinase (MMP2) gene influence metabolic syndrome susceptibility. Genet Test Mol Biomarkers. 2014;18:88–92. doi: 10.1089/gtmb.2013.0361. PubMed DOI

YUN MJ, KIM YK, KANG DM, KIM JE, HA WC, JUNG KY, CHOI HW. A study on prevalence and risk factors for varicose veins in nurses at a university hospital. Saf Health Work. 2018;9:79–83. doi: 10.1016/j.shaw.2017.08.005. PubMed DOI PMC

ZHAO M-Y, ZHAO T, MENG Q-Y, ZHAO L, LI X-C. Estrogen and estrogen receptor affects MMP2 and MMP9 expression through classical ER pathway and promotes migration of lower venous vascular smooth muscle cells. Eur Rev Med Pharmacol Sci. 2020;24:1460–1467. doi: 10.26355/eurrev_202002_20205. PubMed DOI

ZOLOTUKHIN IA, SELIVERSTOV EI, SHEVTSOV YN, AVAKIANTS IP, NIKISHKOV AS, TATARINTSEV AM, KIRIENKO AI. Prevalence and risk factors for chronic venous disease in the general Russian population. Eur J Vasc Endovasc Surg. 2017;54:752–758. doi: 10.1016/j.ejvs.2017.08.033. PubMed DOI